Julian Chick
Chairman chez CANN GROUP LIMITED
Profil
Julian J.
Chick is currently the Chairman at Cann Group Ltd.
He also holds positions as a Director at Mid-Atlantic BioTherapeutics, Inc. and as an Independent Non-Executive Director at LTR Pharma Ltd.
Previously, he served as the Chief Executive Officer & Director at Tali Digital Ltd.
from 2004 to 2010.
He was also the Chief Operating Officer & Director at Anteris Technologies Ltd.
Additionally, he worked as a Non-Executive Director at Opyl Ltd.
from 2019 to 2023.
Dr. Chick holds a doctorate degree from the University of Oxford and an undergraduate degree from LaTrobe University.
Postes actifs de Julian Chick
Sociétés | Poste | Début |
---|---|---|
CANN GROUP LIMITED | Chairman | 28/08/2023 |
LTR PHARMA LIMITED | Director/Board Member | - |
Mid-Atlantic BioTherapeutics, Inc.
Mid-Atlantic BioTherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Mid-Atlantic BioTherapeutics, Inc. is a clinical-stage pharmaceutical company focused on the clinical development and commercialization of a novel anti-infective therapeutic approach, which is immunotherapy for infectious diseases. The company was founded by David Horn, David Jobes, and Jean-Pierre Gagnon in 2011 and is headquartered in Doylestown, PA. | Director/Board Member | - |
Anciens postes connus de Julian Chick
Sociétés | Poste | Fin |
---|---|---|
OPYL LIMITED | Chairman | 16/09/2022 |
TALI DIGITAL LIMITED | Chief Executive Officer | 31/05/2010 |
ANTERIS TECHNOLOGIES LTD | Chief Operating Officer | - |
Formation de Julian Chick
University of Oxford | Doctorate Degree |
LaTrobe University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 5 |
---|---|
TALI DIGITAL LIMITED | Technology Services |
ANTERIS TECHNOLOGIES LTD | Health Technology |
OPYL LIMITED | Technology Services |
CANN GROUP LIMITED | Process Industries |
LTR PHARMA LIMITED | Health Technology |
Entreprise privées | 1 |
---|---|
Mid-Atlantic BioTherapeutics, Inc.
Mid-Atlantic BioTherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Mid-Atlantic BioTherapeutics, Inc. is a clinical-stage pharmaceutical company focused on the clinical development and commercialization of a novel anti-infective therapeutic approach, which is immunotherapy for infectious diseases. The company was founded by David Horn, David Jobes, and Jean-Pierre Gagnon in 2011 and is headquartered in Doylestown, PA. | Commercial Services |